OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes.
OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes.
Authors: M L Norgaard; S S Andersen; T K Schramm; F Folke; C H Jørgensen; M L Hansen; C Andersson; D M Bretler; A Vaag; L Køber; C Torp-Pedersen; G H Gislason Journal: Diabetologia Date: 2010-05-09 Impact factor: 10.122
Authors: Morten L Hansen; Gunnar H Gislason; Lars Køber; Tina Ken Schramm; Fredrik Folke; Pernille Buch; Steen Z Abildstrom; Mette Madsen; Søren Rasmussen; Christian Torp-Pedersen Journal: Br J Clin Pharmacol Date: 2007-08-15 Impact factor: 4.335
Authors: Casper N Bang; Gunnar H Gislason; Anders M Greve; Christian A Bang; Alexander Lilja; Christian Torp-Pedersen; Per K Andersen; Lars Køber; Richard B Devereux; Kristian Wachtell Journal: J Am Heart Assoc Date: 2014-01-21 Impact factor: 5.501
Authors: Carlo A Barcella; Talip E Eroglu; Michiel Hulleman; Asger Granfeldt; Patrick C Souverein; Grimur H Mohr; Rudolph W Koster; Mads Wissenberg; Anthonius de Boer; Christian Torp-Pedersen; Fredrik Folke; Marieke T Blom; Gunnar H Gislason; Hanno L Tan Journal: Europace Date: 2020-08-01 Impact factor: 5.214
Authors: Anne Frølich; Michaela L Schiøtz; Martin Strandberg-Larsen; John Hsu; Allan Krasnik; Finn Diderichsen; Jim Bellows; Jes Søgaard; Karen White Journal: BMC Health Serv Res Date: 2008-12-11 Impact factor: 2.655
Authors: Wolfgang C Winkelmayer; Anna E Bucsics; Alexandra Schautzer; Peter Wieninger; Michaela Pogantsch Journal: Eur J Epidemiol Date: 2007-12-07 Impact factor: 8.082